Cost-Effectiveness of PET-Directed vs. Combined Modality Therapy for Early Stage Hodgkin Lymphoma
ABVD
Dacarbazine
Hodgkin's lymphoma
DOI:
10.1016/j.ijrobp.2020.07.2491
Publication Date:
2020-10-24T00:02:33Z
AUTHORS (5)
ABSTRACT
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (0)
CITATIONS (0)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....